BSE:538634

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Vasundhara Rasayans Limited manufactures and sells antacids therapeutic category of active pharmaceutical ingredients primarily in India. More Details


Snowflake Analysis

Flawless balance sheet with solid track record.


Similar Companies

Share Price & News

How has Vasundhara Rasayans's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 538634 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 538634's weekly volatility (7%) has been stable over the past year.


Market Performance


7 Day Return

-4.1%

538634

-3.5%

IN Pharmaceuticals

-0.7%

IN Market


1 Year Return

205.6%

538634

51.5%

IN Pharmaceuticals

17.3%

IN Market

Return vs Industry: 538634 exceeded the Indian Pharmaceuticals industry which returned 51.5% over the past year.

Return vs Market: 538634 exceeded the Indian Market which returned 17.3% over the past year.


Shareholder returns

538634IndustryMarket
7 Day-4.1%-3.5%-0.7%
30 Day-3.4%2.2%8.4%
90 Day26.1%8.4%23.0%
1 Year210.4%205.6%53.3%51.5%19.5%17.3%
3 Year88.3%79.7%38.8%35.4%8.9%3.6%
5 Year128.1%117.7%23.1%18.9%81.8%67.9%

Long-Term Price Volatility Vs. Market

How volatile is Vasundhara Rasayans's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Vasundhara Rasayans undervalued compared to its fair value and its price relative to the market?

7.51x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 538634 (₹82.5) is trading above our estimate of fair value (₹22.16)

Significantly Below Fair Value: 538634 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 538634 is good value based on its PE Ratio (7.5x) compared to the IN Pharmaceuticals industry average (23.6x).

PE vs Market: 538634 is good value based on its PE Ratio (7.5x) compared to the Indian market (19.2x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 538634's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 538634 is good value based on its PB Ratio (1.3x) compared to the IN Pharmaceuticals industry average (2.5x).


Next Steps

Future Growth

How is Vasundhara Rasayans forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.1%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Vasundhara Rasayans has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Vasundhara Rasayans performed over the past 5 years?

8.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 538634 has high quality earnings.

Growing Profit Margin: 538634's current net profit margins (16.1%) are higher than last year (3.4%).


Past Earnings Growth Analysis

Earnings Trend: 538634's earnings have grown by 8.4% per year over the past 5 years.

Accelerating Growth: 538634's earnings growth over the past year (420.6%) exceeds its 5-year average (8.4% per year).

Earnings vs Industry: 538634 earnings growth over the past year (420.6%) exceeded the Pharmaceuticals industry 29.5%.


Return on Equity

High ROE: 538634's Return on Equity (17.9%) is considered low.


Next Steps

Financial Health

How is Vasundhara Rasayans's financial position?


Financial Position Analysis

Short Term Liabilities: 538634's short term assets (₹272.3M) exceed its short term liabilities (₹78.2M).

Long Term Liabilities: 538634's short term assets (₹272.3M) exceed its long term liabilities (₹2.7M).


Debt to Equity History and Analysis

Debt Level: 538634 is debt free.

Reducing Debt: 538634 has no debt compared to 5 years ago when its debt to equity ratio was 75.5%.

Debt Coverage: 538634 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 538634 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Vasundhara Rasayans's current dividend yield, its reliability and sustainability?

1.82%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 538634's dividend (1.82%) is higher than the bottom 25% of dividend payers in the Indian market (0.44%).

High Dividend: 538634's dividend (1.82%) is low compared to the top 25% of dividend payers in the Indian market (1.87%).


Stability and Growth of Payments

Stable Dividend: 538634 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 538634's dividend payments have increased, but the company has only paid a dividend for 6 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (13.7%), 538634's dividend payments are thoroughly covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.8yrs

Average management tenure


CEO

Rajesh Pokerna (55 yo)

15.25yrs

Tenure

₹1,800,000

Compensation

Mr. Rajesh Pokerna has been Managing Director and Whole Time Director of Vasundhara Rasayans Ltd. since July 10, 2005.


CEO Compensation Analysis

Compensation vs Market: Rajesh's total compensation ($USD24.67K) is below average for companies of similar size in the Indian market ($USD44.77K).

Compensation vs Earnings: Rajesh's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Rajesh Pokerna
MD & Whole Time Director15.25yrs₹1.80mno data
Sunil Jain
CFO & Whole Time Director12.75yrs₹800.00kno data
Sanjay Jain
Whole Time Director12.75yrs₹800.00kno data
Prakash Jain
Whole Time Director15.25yrs₹750.00k0.016%
₹ 42.7k
Santosh Jha
Company Secretary & Compliance Officer0.42yrno datano data

5.8yrs

Average Tenure

56.5yo

Average Age

Experienced Management: 538634's management team is seasoned and experienced (5.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Rajesh Pokerna
MD & Whole Time Director15.25yrs₹1.80mno data
Sunil Jain
CFO & Whole Time Director12.75yrs₹800.00kno data
Sanjay Jain
Whole Time Director12.75yrs₹800.00kno data
Prakash Jain
Whole Time Director15.25yrs₹750.00k0.016%
₹ 42.7k
Rajiv Kakodkar
Non-Executive Independent Director6.33yrsno datano data
Pravinchandra Popatlal
Non-Executive Independent Director6.33yrsno datano data
Rajesh Jain
Non-Executive Independent Director6.33yrsno datano data
Pradeep Jain
Independent Directorno datano data2.99%
₹ 8.1m
Seema Jain
Independent Woman Director5.83yrs₹600.00kno data

9.5yrs

Average Tenure

56yo

Average Age

Experienced Board: 538634's board of directors are considered experienced (9.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Vasundhara Rasayans Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Vasundhara Rasayans Limited
  • Ticker: 538634
  • Exchange: BSE
  • Founded: 1987
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₹271.259m
  • Shares outstanding: 3.18m
  • Website: https://www.vasundhararasayans.in

Number of Employees


Location

  • Vasundhara Rasayans Limited
  • Shed No. 42
  • Phase II
  • Hyderabad
  • 500076
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
538634BSE (Mumbai Stock Exchange)YesEquity SharesININRSep 2014

Biography

Vasundhara Rasayans Limited manufactures and sells antacids therapeutic category of active pharmaceutical ingredients primarily in India. Its products include aluminum hydroxide gel, magnesium hydroxide, m...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/22 12:25
End of Day Share Price2021/01/22 00:00
Earnings2020/09/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.